Can you elaborate on share documents on this? I’m wondering why east asia is different in anti fungal usage.
"I’m wondering why east asia is different in anti fungal usage."
It is a logical error to assume that it has to be substantially different. East Asia is simply the region that Candida auris originates from (ie., evolved in). It was first noticed in Tokyo and South Korea, and eventually India a few years later.
EDIT:
Actually, looks like there's some evidence that multiple evolutionarily-separate unrelated strains attained drug resistance one after another. Presumably the same antifungal agricultural product would have been in widespread use if this is the cause. If you look at the PLOS article linked in the NYT article in my link, they give an example of this for Aspergillus fumigatus strains.
[1] https://journals.plos.org/plospathogens/article?id=10.1371/j...